======= SUDS3 ======= == Gene Information == * **Official Symbol**: SUDS3 * **Official Name**: SDS3 homolog, SIN3A corepressor complex component * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=64426|64426]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H7L9|Q9H7L9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SUDS3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SUDS3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608250|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulatory protein which represses transcription and augments histone deacetylase activity of HDAC1. May have a potential role in tumor suppressor pathways through regulation of apoptosis. May function in the assembly and/or enzymatic activity of the mSin3A corepressor complex or in mediating interactions between the complex and other regulatory complexes. {ECO:0000269|PubMed:12724404, ECO:0000269|PubMed:21239494}. |Sds3| |Sin3-type complex| |Sin3 complex| |histone deacetylase activity| |substantia nigra development| |histone deacetylation| |protein deacetylation| |protein deacylation| |macromolecule deacylation| |neural nucleus development| |midbrain development| |histone deacetylase binding| |protein deubiquitination| |nuclear body| |protein modification by small protein removal| |enzyme binding| |histone modification| |covalent chromatin modification| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |positive regulation of cell death| |chromatin organization| |brain development| |head development| |negative regulation of transcription by RNA polymerase II| |apoptotic process| |central nervous system development| |protein modification by small protein conjugation or removal| |programmed cell death| |chromosome organization| |cell death| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |proteolysis| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |negative regulation of biosynthetic process| |regulation of programmed cell death| |regulation of cell death| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.06| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|-1.95| |[[:results:exp422|Wiskostatin 3μM R07 exp422]]|-1.83| |[[:results:exp437|Ethanol 0.003 R08 exp437]]|-1.82| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|1.8| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|1.85| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|2.07| |[[:results:exp303|39°C R06 exp303]]|2.51| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|2.6| ^Gene^Correlation^ |[[:human genes:i:ing1|ING1]]|0.568| |[[:human genes:b:brms1|BRMS1]]|0.528| |[[:human genes:s:sap130|SAP130]]|0.517| |[[:human genes:s:sin3a|SIN3A]]|0.492| |[[:human genes:b:brd1|BRD1]]|0.403| Global Fraction of Cell Lines Where Essential: 4/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|1/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|1/1| |skin|0/24| |soft tissue|1/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2759 * **Expression level (log2 read counts)**: 6.23 {{:chemogenomics:nalm6 dist.png?nolink |}}